Results

Total Results: over 10,000 records

Showing results for "drug".

61. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
    October 05, 2018 - /class, time between drug initiation and start of drug holiday, duration of drug holiday, post-drug … (pre-drug holiday agent/class, time between drug initiation and start of drug holiday, duration of … : pre-drug holiday agent/class, time between drug initiation and start of drug holiday, duration … of drug holiday, post-drug holiday agent/class Continued osteoporosis drug treatment after >1 yr … characteristics: pre-drug holiday agent/class, time between drug initiation and start of drug holiday

62. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
    October 05, 2018 - /class, time between drug initiation and start of drug holiday, duration of drug holiday, post-drug … (pre-drug holiday agent/class, time between drug initiation and start of drug holiday, duration of … : pre-drug holiday agent/class, time between drug initiation and start of drug holiday, duration … of drug holiday, post-drug holiday agent/class Continued osteoporosis drug treatment after >1 yr … characteristics: pre-drug holiday agent/class, time between drug initiation and start of drug holiday

63. Information technology-based approaches to reducing repeat drug exposure in patients with known drug allergies. | PSNet
    psnet.ahrq.gov/issue/information-technology-based-approaches-reducing-repeat-drug-exposure-patients-known-drug
    December 21, 2022 - Commentary Information technology-based approaches to reducing repeat drug exposure … in patients with known drug allergies. … Information technology-based approaches to reducing repeat drug exposure in patients with known drug … Information technology-based approaches to reducing repeat drug exposure in patients with known drug … Perspective: Topics in Medication Safety March 31, 2022 Safe Practices for Drug

64. Adherence to drug–drug interaction alerts in high-risk patients: a trial of context-enhanced alerting. | PSNet
    psnet.ahrq.gov/issue/adherence-drug-drug-interaction-alerts-high-risk-patients-trial-context-enhanced-alerting
    February 21, 2018 - Study Adherence to drug–drug interaction alerts in high-risk patients: a trial of … Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-enhanced alerting … This randomized controlled trial found that tailoring drug–drug interaction alerts with relevant laboratory … Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-enhanced alerting … 25, 2011 The development and evaluation of an integrated electronic prescribing and drug

65. Reducing drug prescription errors and adverse drug events by application of a probabilistic, machine-learning based clinical decision support system in an inpatient setting. | PSNet
    psnet.ahrq.gov/issue/reducing-drug-prescription-errors-and-adverse-drug-events-application-probabilistic-machine
    March 12, 2025 - Study Reducing drug prescription errors and adverse drug events by application of … Reducing drug prescription errors and adverse drug events by application of a probabilistic, machine-learning … Reducing drug prescription errors and adverse drug events by application of a probabilistic, machine-learning … February 1, 2023 Allergic adverse drug events after alert overrides in hospitalized … September 21, 2022 Improving the specificity of drug-drug interaction alerts: can it

66. Final Report: Improving Drug Safety (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/magid-report.pdf
    January 01, 2024 - Final Report: Improving Drug Safety Final Report: Improving Drug Safety PI: David Magid, MD, MPH … ordering, dispensing, drug administration, and/or drug therapy monitoring for efficacy or toxicity. … patients, drug dosing and frequency errors, administration route errors, drug substitution errors, … interactions; drug-lab checks; and drug selection and dosing in children, the elderly, pregnancy, renal … Improving Drug Safety 1 UC1 HS14249 16 The Improving Drug Safety project was part of a larger

67. Drug–drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records. | PSNet
    psnet.ahrq.gov/issue/drug-drug-interactions-should-be-non-interruptive-order-reduce-alert-fatigue-electronic
    December 31, 2014 - Study Drug–drug interactions that should be non-interruptive in order to reduce alert … Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic … Alert fatigue is particularly common in drug–drug interaction (DDI) alerts, with prior studies reporting … Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic … March 4, 2015 Time-dependent drug–drug interaction alerts in care provider order entry

68. HL7 Drug Order Examples
    hcup-us.ahrq.gov/datainnovations/clinicalcontentenhancementtoolkit/mn18.jsp
    September 07, 2014 - HL7 Drug Order Examples … Order Examples The following are examples of HL7 segments containing drug order data. … New Order for oral drug give once ORC|NW|20352777|||AC||||201108250625 RXE|^NOW^^201108250625|WARF5 … Discontinuation order for intravenous drug ranitidine in sodium chloride ORC|DC|18686^EFG||||^Q8& … |195^Sodium Chloride 0.9% 100 mL|100|mL 8/26/2011 Internet Citation: HL7 Drug

69. HL7 Drug Order Examples (pdf file)
    hcup-us.ahrq.gov/datainnovations/clinicalcontentenhancementtoolkit/mn18.pdf
    June 21, 2014 - HL7 Drug Order Examples 8/26/2011 The following are examples of HL7 segments containing drug order … fields in each of these segments or describe the HL7 messaging process but to show the minimum type of drug … New Order for oral drug give once ORC|NW|20352777|||AC||||201108250625 RXE|^NOW^^201108250625|WARF5 … New order for oral drug with specified start and stop time ORC|NW|28833^EFG|||||^DAILY&0900^^20110812110000 … Discontinuation order for intravenous drug ranitidine in sodium chloride ORC|DC|18686^EFG||||^Q8&0600,1400,2200

70. Novel Drug Misuse | PSNet
    psnet.ahrq.gov/web-mm/novel-drug-misuse
    September 30, 2010 - SPOTLIGHT CASE Novel Drug Misuse Citation Text: Angus DC, Milbrandt EB. … Novel Drug Misuse. PSNet [internet]. … Novel Drug Misuse. PSNet [internet]. … Patients had to receive the drug within 48 hours of the onset of sepsis. … Novel Drug Misuse. PSNet [internet].

71. The impact of drug error reduction software on preventing harmful adverse drug events in England: a retrospective database study. | PSNet
    psnet.ahrq.gov/issue/impact-drug-error-reduction-software-preventing-harmful-adverse-drug-events-england
    November 16, 2022 - Study The impact of drug error reduction software on preventing harmful adverse drug … The impact of drug error reduction software on preventing harmful adverse drug events in England: a retrospective … The impact of drug error reduction software on preventing harmful adverse drug events in England: a retrospective … November 16, 2022 Improving the specificity of drug-drug interaction alerts: can it be … June 16, 2021 Preventable adverse drug events causing hospitalisation: identifying root

72. Are we heeding the warning signs? Examining providers' overrides of computerized drug–drug interaction alerts in primary care. | PSNet
    psnet.ahrq.gov/issue/are-we-heeding-warning-signs-examining-providers-overrides-computerized-drug-drug-interaction
    September 01, 2016 - Examining providers' overrides of computerized drug–drug interaction alerts in primary care. … Examining providers' overrides of computerized drug-drug interaction alerts in primary care. … This study investigated how often and why providers overrode drug–drug interaction (DDI) warnings in … Examining providers' overrides of computerized drug-drug interaction alerts in primary care. … August 17, 2018 View More Related Resources Adherence to drug–drug

73. National rules for drug-drug interactions: are they appropriate for tertiary hospitals? | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/national
    January 01, 2023 - National rules for drug-drug interactions: are they appropriate for tertiary hospitals? … National rules for drug-drug interactions: are they appropriate for tertiary hospitals?

74. Improving the specificity of drug-drug interaction alerts: Can it be done? | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/improving
    January 01, 2023 - Improving the specificity of drug-drug interaction alerts: Can it be done? … Improving the specificity of drug-drug interaction alerts: Can it be done? … Project Name Meaningful Drug Interaction Alerts Technology Clinical Decision Support

75. Drug Abuse | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/drug-abuse
    April 01, 2021 - Home Health Topics D Drug … Each year drug abuse causes millions of serious illnesses or injuries among Americans. … Drug abuse can lead to homelessness, crime, and missed work or problems with keeping a job. … There are different types of treatment for drug abuse. … But the best is to prevent drug abuse in the first place.

76. Drug manufacturers' delayed disclosure of serious and unexpected adverse events to the US Food and Drug Administration. | PSNet
    psnet.ahrq.gov/issue/drug-manufacturers-delayed-disclosure-serious-and-unexpected-adverse-events-us-food-and-drug
    July 10, 2017 - to the US Food and Drug Administration. … Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug … This study examined adverse drug events reported to the FDA by manufacturers. … Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug … A proposed rule by the Food and Drug Administration.

77. Time-dependent drug–drug interaction alerts in care provider order entry: software may inhibit medication error reductions. | PSNet
    psnet.ahrq.gov/issue/time-dependent-drug-drug-interaction-alerts-care-provider-order-entry-software-may-inhibit
    March 10, 2011 - Study Time-dependent drug–drug interaction alerts in care provider order entry: software … Time-dependent drug-drug interaction alerts in care provider order entry: software may inhibit medication … computerized provider order entry system were not able to prevent medication errors resulting from drug–drug … Time-dependent drug-drug interaction alerts in care provider order entry: software may inhibit medication … September 1, 2016 Critical drug–drug interactions for use in electronic health records

78. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014. | PSNet
    psnet.ahrq.gov/issue/completeness-serious-adverse-drug-event-reports-received-us-food-and-drug-administration-2014
    September 25, 2008 - and Drug Administration in 2014. … Completeness of serious adverse drug event reports received by the US Food and Drug Administration in … According to this study, many adverse drug event reports submitted by drug manufacturers to the Food … and Drug Administration were incomplete. … Completeness of serious adverse drug event reports received by the US Food and Drug Administration in

79. High-priority drug-drug interactions for use in electronic health records. | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-9
    January 01, 2023 - High-priority drug-drug interactions for use in electronic health records. … High-priority drug-drug interactions for use in electronic health records. … High-priority drug-drug interactions for… Principal Investigator Bates, David Project

80. Barriers to adoption of tailored drug-drug interaction clinical decision support. | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/barriers
    January 01, 2023 - Barriers to adoption of tailored drug-drug interaction clinical decision support. … Barriers to adoption of tailored drug-drug interaction clinical decision support. … Project Name Meaningful Drug Interaction Alerts Technology Clinical Decision Support